📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Treatment with specific and pan-plasma membrane calcium ATPase (PMCA) inhibitors reduces malaria parasite growth in vitro and in vivo. (2022)

First Author: Asih PBS

Attributed to: The role of plasma membrane calcium ATPase 4 (PMCA4) in modulating Plasmodium infection and malaria severity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12936-022-04228-0

PubMed Identifier: 35768835

Publication URI: http://europepmc.org/abstract/MED/35768835

Type: Journal Article/Review

Volume: 21

Parent Publication: Malaria journal

Issue: 1

ISSN: 1475-2875